Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

LAMPA

From Wikipedia, the free encyclopedia
(Redirected fromLysergic acid methylpropylamide)
Chemical compound

Pharmaceutical compound
LAMPA
Clinical data
Other namesLysergic acid methylpropylamide; LMP; LAMP; LAMPA; LMP-55; LMP55; MPLA;N-Methyl-N-propyllysergamide;N,6-Dimethyl-N-propyl-9,10-didehydroergoline-8β-carboxamide
Legal status
Legal status
Identifiers
  • N,7-dimethyl-N-propyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChemCID
ChemSpider
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC20H25N3O
Molar mass323.440 g·mol−1
3D model (JSmol)
  • CCCN(C)C(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C
  • InChI=InChI=1S/C20H25N3O/c1-4-8-22(2)20(24)14-9-16-15-6-5-7-17-19(15)13(11-21-17)10-18(16)23(3)12-14/h5-7,9,11,14,18,21H,4,8,10,12H2,1-3H3
  • Key:CZRJGQXHVRNZRZ-UHFFFAOYSA-N

Lysergic acid methylpropylamide (LAMPA,LAMP, orLMP), also known asLMP-55 or asN-methyl-N-propyllysergamide (MPLA), is a structural analogue oflysergic acid diethylamide (LSD) that has been studied as a potential treatment foralcoholism.[1] In animal studies, LAMPA was found to be nearly equipotent toECPLA andMIPLA for inducing ahead-twitch response. LAMPA appears to be significantly less potent than LSD in humans, producing little to no noticeable effects at doses of 100 μg.[2] It shows reduced-efficacypartial agonism of theserotonin5-HT2A receptor relative to LSD, which may be responsible for its equivocal hallucinogenic effects.[3]

See also

[edit]

References

[edit]
  1. ^Abramson HA, Rolo A (1967)."Comparison of LSD with methysergide and psilocybin on test subjects."(PDF). In Abramson HA (ed.).The use of LSD in psychotherapy and alcoholism. Bobbs-Merrill Company Inc. pp. 53–57. Retrieved15 May 2022.
  2. ^Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, et al. (February 2019)."Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)".Psychopharmacology.236 (2):799–808.doi:10.1007/s00213-018-5055-9.PMC 6848745.PMID 30298278.
  3. ^Pottie E, Glatfelter GC, Baumann MH, Stove CP (2024)."Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor".Emerging Trends in Drugs, Addictions, and Health.4 100109.doi:10.1016/j.etdah.2023.100109.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Ergolines
(incl.lysergines)
Clavines
(6,8-dimethylergolines)
Lysergamides
(lysergic acid amides)
Ergopeptines
(peptide ergolines)
Partial ergolines
Related compounds
Natural sources
Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=LAMPA&oldid=1318169079"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp